PSTV

#4453
PLUS THERAPEUTICS, Inc. Common Stock
5.43 USD
+0.37%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
5.43
5.43
Rango anual
0.13
5.72
Cambio diario
+0.37%
Variación mensual
+1911.11%
Variación en los últimos 6 meses
+664.79%
Cambio anual
+686.96%
Cierres anteriores
5.41
Abrir
5.43
Bid
Ask
Mínimo
5.43
High
5.43
Volumen
13
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 37.26 M
  • Employee 28
  • Founded 1996
  • CEO N/A
  • Website www.plustherapeutics.com
  • Headquarter Delaware, United States
  • FIGI BBG000C1Z086
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.77
Relación precio/flujo de caja
7.65

PLUS THERAPEUTICS Inc

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®.

Noticias